Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
287
287 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SugemalimabPhase 32 trials
Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma
- TGRX-326once a dayPhase 32 trials
Shenzhen TargetRx Co., Ltd. · Non-small Cell Lung Cancer, Non Small Cell Lung Cancer
- TQB2450Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer
- UliledlimabPhase 32 trials
TJ Biopharma Co., Ltd. · Non Small Cell Lung Cancer
- US-sourced KeytrudaPhase 32 trials
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer
- VEGF bispecific antibodyPhase 32 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Squamous Non-small-cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer
- VT3989Phase 32 trials
Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult
- ABBV-1480Phase 31 trial
AbbVie · Non-Small Cell Lung Cancer
- adebelizumabPhase 31 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced or Metastatic Non-small Cell Lung Cancer
- Alflutinib MesylatePhase 31 trial
Allist Pharmaceuticals, Inc. · Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
- FHND9041Phase 31 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer
- HLX17Phase 31 trial
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer
- HS-20117PM1080Phase 31 trial
Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer
- IcotinibPhase 31 trial
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- IptilimumabPhase 31 trial
InSightec · Brain Tumor, Non Small Cell Lung Cancer
- JMKX001899Phase 31 trial
Jemincare · NSCLC (Non-small Cell Lung Cancer)
- MB12Proposed Pembrolizumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer
- PaxlitaxelPhase 31 trial
Akeso · Advanced Squamous Non Small Cell Lung Cancer
- PlinabulinPhase 31 trial
BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- SB27Phase 31 trial
Samsung Bioepis Co., Ltd. · Non-small Cell Lung Cancer Stage IV
- SH-1028Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer
- YK-209APhase 31 trial
Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- MK-4830Phase 210 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma
- SI-B003Phase 210 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
- SHR-9839Phase 28 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)
- RO7247669Tobemstomig, RG6139Phase 26 trials
Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer
- SKB571Phase 26 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors
- Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials
Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)
- GFH276Phase 25 trials
Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)
- PalacaparibAZD9574Phase 25 trials
AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer
- SHR-1826Phase 25 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer
- Zelenectide pevedotinBT8009Phase 25 trials
BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors
- AB928Etrumadenant, ETRUMAPhase 24 trials
Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
- ABSK043Phase 24 trials
Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer
- BenmelstobartPhase 24 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer, Gastroesophageal Adenocarcinoma
- EnvafolimabPhase 24 trials
3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors
- GecacitinibPhase 24 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor
- IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials
Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma
- TUB-040Phase 24 trials
Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer
- UbamatamabREGN4018Phase 24 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- VS-7375Phase 24 trials
Verastem, Inc. · G12D Mutated KRAS, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)
- ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials
MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer
- AK146D1Phase 23 trials
Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)
- AnvumetostatAMG 193Phase 23 trials
Amgen · Advanced MTAP-null Solid Tumors, MTAP-deleted NSCLC, MTAP-null Non-Small-Cell Lung Cancer
- AZD4205Phase 23 trials
Dizal Pharmaceuticals · Non-small Cell Lung Cancer, Peripheral T-cell Lymphoma, Peripheral T Cell Lymphoma
- BoserolimabMK-5890Phase 23 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer
- BT5528nuzefatide pevedotinPhase 23 trials
BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer
- GV20-0251Phase 23 trials
GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum
- IAP0971Phase 23 trials
SUNHO(China)BioPharmaceutical CO., Ltd. · Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer, Bladder Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.